News

Capsa Healthcare's Innovative Solutions at ASHP Midyear 2025

Capsa Healthcare's Innovative Solutions at ASHP Midyear 2025

Capsa Healthcare to Present at ASHP Midyear 2025

Capsa Healthcare, recognized for its innovative approach in medication management, is gearing up to showcase its cutting-edge pharmacy automation solutions at the upcoming ASHP Midyear Clinical Meeting and Exhibition. Attendees can find the company at Booth #641, where they will get an in-depth look at how Capsa’s advanced systems are designed to tackle labor challenges while enhancing efficiency and sustainability in hospital and health system pharmacies.

Highlighting Pharmacy Automation Capabilities

The core of Capsa’s exhibit will be a live demonstration of a fully integrated central fill workflow, illustrating the entire process from prescription intake to packaging and delivery. This comprehensive showcase will feature:

High-Volume Counting Cell (HVC)

The HVC is engineered for enterprise-level automation that can accomplish up to 480 fills per hour. It surpasses the industry standard with an exceptional filling rate, up to 3.5 scripts per square foot, thereby significantly reducing replenishment time by up to 82% and offering remarkable labor savings of at least 50%.

Unit-of-Use Automation

This advanced system is built to handle both prefilled and cold-chain medications, ensuring comprehensive traceability. By automating up to 80% of medication dispensing, it allows for throughput potentially reaching 10,800 packages per hour without compromising accuracy or compliance, resulting in substantial labor efficiencies.

Medium Volume and Manual Fill Stations

Capsa offers flexible solutions tailored for smaller SKUs and specialty medications. These stations integrate seamlessly into the Central Fill ecosystem, offering versatility for various pharmacy needs.

Consolidated Services Pharmacy Platform (CSPP)

The CSPP is a cloud-native software that facilitates efficient order routing, inventory management, and compliance with medications regulations like DSCSA and 340B. It ensures that all prescriptions are synchronized across the entire central fill operation, which significantly enhances operational efficiency.

Astral AI: Leveraging Analytics for Better Outcomes

This AI-driven analytics platform provides valuable insights into workflow performance, staffing efficiency, SKU allocation, and predictive maintenance strategies, enabling pharmacies to optimize their operations further. By deploying Astral AI, health system pharmacies can make data-driven decisions that enhance both workflow and service delivery quality.

Tackling Pharmacy Challenges

Capsa’s innovative central fill and mail-order (CFMO) systems are critical in helping health systems smoothly navigate operational challenges and labor constraints. By effectively integrating automation with intelligent orchestration through CSPP, pharmacies can reduce their cost to fill below $1 per script, streamline their workflows, and allow pharmacists to focus on direct patient care instead of behind-the-scenes tasks.

Connect with Capsa Healthcare at ASHP Midyear 2025

For those looking to explore how to elevate their pharmacy operations, a visit to Capsa Healthcare’s booth at ASHP Midyear is highly recommended. Attendees are encouraged to schedule a consultation with Capsa's automation specialists, who will explain how the company’s Central Fill solutions, powered by CSPP and Astral AI, provide the accuracy and efficiency required by modern hospital and health system pharmacies.

About Capsa Healthcare

As a leader in the medication management sector, Capsa Healthcare has been at the forefront of healthcare technology for over 50 years. The company focuses on designing and manufacturing solutions that enhance workflow efficiency, improve clinical accuracy, and elevate patient care delivery across the healthcare continuum.

Media Contact Information

For media inquiries, please contact:
Timothy Hankins
Marketing Communications Manager
Capsa Healthcare
Email: thankins@capsahealthcare.com
Website: www.capsahealthcare.com

Frequently Asked Questions

What is the focus of Capsa Healthcare at ASHP Midyear 2025?

Capsa Healthcare will focus on showcasing its pharmacy automation solutions to improve operational efficiency in health system pharmacies.

What are the benefits of the High-Volume Counting Cell?

The HVC can achieve up to 480 fills per hour while significantly reducing operational costs and replenishment times.

How does the Unit-of-Use Automation work?

This system automates medication dispensing, allowing for high throughput while maintaining accuracy and compliance.

What is the role of the Consolidated Services Pharmacy Platform?

CSPP streamlines inventory management and ensures compliance across all aspects of pharmacy operations.

Where can I find Capsa Healthcare at the ASHP event?

Capsa will be at Booth #641 during the ASHP Midyear Clinical Meeting & Exhibition.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 33

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 32

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 25

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 32

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

TKO Group Launches Major Share Buyback and Dividend Initiative

Updated Category News Views 669

TKO Group Announces Strategic Financial Moves TKO Group Holdings, Inc. (NYSE: TKO) has recently made headlines with its announcement of a remarkable share repurchase program amounting to $2 billion. Alongside this significant initiative, the company is introducing a quarterly cash dividend that is projected to reach $75 million. These strategic financial maneuvers reflect...

Continue Reading
An Insightful Look at Warner Bros. Discovery's Declining Short Interest

Updated Category News Views 64

Understanding Warner Bros. Discovery's Short Interest Trends Warner Bros. Discovery (WBD) has seen a noteworthy drop in its short percent of float, falling by 11.22% since the last report. Currently, the company reports that there are 101.75 million shares sold short, representing about 4.67% of all available shares for trading. Interestingly, based on the current trading...

Continue Reading
Avobis Bio Advances Clinical Trials for Innovative Therapy Solutions

Updated Category News Views 185

Avobis Bio Unveils Breakthrough in Clinical Trial for AVB-114 Avobis Bio LLC, a pioneering company focused on developing innovative implantable cell therapies, has made a remarkable stride by completing the primary analysis of the STOMP-II randomized clinical trial targeting Crohn's perianal fistulas. This analysis brings with it exciting prospects for FDA interaction and...

Continue Reading
Innovative Bait Accessory Enhances Fishing Experience

Updated Category News Views 239

Revolutionizing Fishing with a New Bait Accessory Fishing is more than just a hobby; it's a passion for many outdoor enthusiasts. That's why the recent invention of the E Z BAIT accessory is creating waves in the angling community. Designed for all fishing lovers, it aims to keep your bait right where you need it without missing a beat. Convenience at Your Fingertips...

Continue Reading
Oncoinvent ASA: Advancing Cancer Therapies with Financial Focus

Updated Category News Views 158

Oncoinvent ASA's Periodic Performance Highlights Oncoinvent is making strides in the oncology sector, particularly with its Phase 2 trial for ovarian cancer. This clinical-stage biotechnology company is diligently focusing on expanding its research scope while ensuring sound financial management practices. Their primary product, Radspherin®, is a radiopharmaceutical...

Continue Reading